Received Feb 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | 1 | — | — |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | — | — |
no additional adverse event was reported; then PREVNAR 20 was mistakenly administered on 2/3/2025 to the same patient at a different location; This spontaneous report was received from Other Health Professional and refers to a. The patient's medical history was not reported. The patient's concurrent conditions included prophylaxis. Concomitant therapies were not reported. On 23-OCT-2024, the patient was vaccinated with first dose of pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) injection, unk, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided). On 03-FEB-2025, the patient was mistakenly vaccinated with pneumococcal vaccine conj 20v (crm197) (PREVNAR 20), unk, administered for prophylaxis (strength, formulation, lot #, expiry date, and route of administration were not provided) (Wrong product administered). No additional adverse event was reported.
Prophylaxis